Express Pharma
Home  »  Latest Updates  »  Antares Vision receives EC grant

Antares Vision receives EC grant

Read Article

New technology for inspection of lyophilised injectables to be developed

Antares Vision, provider of serialisation-based track and trace solutions for the pharmaceutical industry, has been awarded a highly selective European Commission (EC) Grant to develop new technology for the inspection of injectable lyophilised pharma products. The Lyo-Check Project will see development of a fully automated industrial machine for 100 per cent inspection of lyophiles based on innovative vision architecture – a dedicated software and optical layout combined with ancillary technology – as well as Headspace Gas Analysis (HGSA) for testing product sterility via container integrity inspection.

With the goal of producing a disruptive inspection innovation for the pharma industry, the grant has been awarded within the EU Horizon 2020’s Small and Medium Enterprises (SME) instrument framework. The SME instrument is part of the largest EU Research and Innovation Program ever, which aims to promote breakthroughs, discoveries and world-firsts by funding promising ideas from concept to lab to market.

Comments are closed.